이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

DongKook Pharmaceutical 미래 성장

Future 기준 확인 1/6

DongKook Pharmaceutical (는) 각각 연간 15.2% 및 9.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 14.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.2% 로 예상됩니다.

주요 정보

15.2%

수익 성장률

14.6%

EPS 성장률

Pharmaceuticals 수익 성장	36.0%
매출 성장률	9.9%
향후 자기자본 수익률	11.2%
애널리스트 커버리지	Low
마지막 업데이트	19 Apr 2024

최근 미래 성장 업데이트

Recent updates

These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well

May 29

We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt

May 06

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 06

How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?

Mar 15

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?

Feb 28

DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 14

DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly

Feb 01

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 19

The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio

Jan 06

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24

With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting

Dec 21

What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?

Dec 08

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It

Nov 23

수익 및 매출 성장 예측

KOSDAQ:A086450 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (KRW Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	981,600	72,300	N/A	73,800	1
12/31/2025	893,800	73,100	75,000	76,150	2
12/31/2024	810,500	55,300	54,200	70,800	1
3/31/2024	747,013	50,824	5,645	43,834	N/A
12/31/2023	730,994	47,175	2,203	41,793	N/A
9/30/2023	709,543	47,474	-4,834	38,961	N/A
6/30/2023	692,794	47,157	6,550	41,667	N/A
3/31/2023	676,772	53,230	7,390	43,763	N/A
12/31/2022	661,647	52,896	-11,064	40,909	N/A
9/30/2022	645,744	58,943	-2,673	45,738	N/A
6/30/2022	631,065	55,611	-12,494	48,082	N/A
3/31/2022	615,974	50,919	-16,170	49,477	N/A
12/31/2021	594,193	50,345	-5,022	44,654	N/A
9/30/2021	585,740	43,945	1,639	47,422	N/A
6/30/2021	588,360	52,484	25,343	60,698	N/A
3/31/2021	572,391	54,515	5,616	48,930	N/A
12/31/2020	559,103	55,925	17,814	59,108	N/A
9/30/2020	544,685	63,502	19,859	65,202	N/A
6/30/2020	520,469	61,569	13,244	59,474	N/A
3/31/2020	502,390	60,360	38,679	68,633	N/A
12/31/2019	482,280	56,312	44,377	69,483	N/A
9/30/2019	456,230	53,797	-13,023	60,123	N/A
6/30/2019	436,293	50,618	-28,598	49,945	N/A
3/31/2019	418,583	49,157	-40,695	32,790	N/A
12/31/2018	400,807	46,949	-42,324	33,209	N/A
9/30/2018	391,801	45,695	8,925	30,618	N/A
6/30/2018	378,388	42,872	24,480	36,546	N/A
3/31/2018	366,905	41,695	25,783	41,149	N/A
12/31/2017	354,768	39,602	N/A	28,659	N/A
9/30/2017	342,293	38,070	N/A	28,869	N/A
6/30/2017	330,629	39,996	N/A	28,465	N/A
3/31/2017	320,349	40,421	N/A	34,431	N/A
12/31/2016	309,690	40,660	N/A	39,412	N/A
9/30/2016	302,007	38,101	N/A	42,036	N/A
6/30/2016	292,760	35,192	N/A	40,984	N/A
3/31/2016	275,174	30,488	N/A	36,877	N/A
12/31/2015	259,930	27,426	N/A	27,143	N/A
9/30/2015	244,766	23,139	N/A	20,752	N/A
6/30/2015	234,686	21,380	N/A	16,372	N/A
3/31/2015	228,197	20,811	N/A	17,437	N/A
12/31/2014	226,014	21,098	N/A	22,737	N/A
9/30/2014	224,391	18,107	N/A	22,406	N/A
6/30/2014	220,612	18,859	N/A	21,157	N/A
3/31/2014	218,094	17,552	N/A	20,954	N/A
12/31/2013	213,086	16,764	N/A	19,860	N/A
9/30/2013	206,332	22,030	N/A	19,471	N/A

애널리스트 미래 성장 예측

수입 대 저축률: A086450 의 연간 예상 수익 증가율( 15.2% )이 saving rate( 2.5% 보다 높습니다. ).

수익 vs 시장: A086450 의 연간 수익( 15.2% ) KR 시장( 28.8% 보다 느리게 성장할 것으로 예상됩니다. 28.8% 연간).

고성장 수익: A086450 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: A086450 의 수익(연간 9.9% ) KR 시장( 10.5% 보다 느리게 성장할 것으로 예상됩니다. 10.5% 연간).

고성장 수익: A086450 의 수익(연간 9.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: A086450 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.2 %).

DongKook Pharmaceutical 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 18%, revenue upgraded

Price target increased by 7.5% to ₩21,500

Price target decreased by 9.1% to ₩20,000

Price target decreased to ₩25,000

Price target increased to ₩29,000

Price target decreased to ₩26,500

Recent updates

These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 18%, revenue upgraded

Full year 2023 earnings: EPS misses analyst expectations

Price target increased by 7.5% to ₩21,500

Upcoming dividend of ₩180 per share at 1.2% yield

Price target decreased by 9.1% to ₩20,000

Upcoming dividend of ₩180 per share

No independent directors

Price target decreased to ₩25,000

Price target increased to ₩29,000

Price target decreased to ₩26,500

No independent directors

Upcoming dividend of ₩180 per share

Price target decreased to ₩26,000

Consensus EPS estimates increase to ₩1,701

Price target decreased to ₩30,500

We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why

How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?

DongKook Pharmaceutical Co., Ltd., Annual General Meeting, Mar 19, 2021

DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?

DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate

New 90-day high: ₩29,700

The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting

New 90-day high: ₩28,750

Price target raised to ₩35,000

What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It

New 90-day low: ₩25,550

Analysts update estimates

Price target raised to ₩29,250

First half earnings released

New 90-day high - ₩160,800

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견